{"id":"https://openalex.org/W2188771619","doi":null,"title":"ASSOCIATION OF DYSLIPIDEMIA AND INFLAMMATORY MARKERS IN TYPE 2 DIABETES MELLITUS","display_name":"ASSOCIATION OF DYSLIPIDEMIA AND INFLAMMATORY MARKERS IN TYPE 2 DIABETES MELLITUS","publication_year":2014,"publication_date":"2014-01-15","ids":{"openalex":"https://openalex.org/W2188771619","mag":"2188771619"},"language":"en","primary_location":{"id":"pmh:oai:CiteSeerX.psu:10.1.1.402.4771","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.402.4771","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://www.ijabpt.com/pdf/53058-DUGGIRALA[1][1].pdf","raw_type":"text"},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5041926484","display_name":"Duggirala Rajarajeswari","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D. Rajarajeswari","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"J. N. Naidu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. N. Naidu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"B. Sowjanya","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B. Sowjanya","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10528","display_name":"Adipokines, Inflammation, and Metabolic Diseases","score":0.9653000235557556,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10528","display_name":"Adipokines, Inflammation, and Metabolic Diseases","score":0.9653000235557556,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.02539999969303608,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.0035000001080334187,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9909999966621399},{"id":"https://openalex.org/keywords/dyslipidemia","display_name":"dyslipidemia","score":1.0},{"id":"https://openalex.org/keywords/inflammatory-markers","display_name":"inflammatory markers","score":0.859000027179718},{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.9869999885559082},{"id":"https://openalex.org/keywords/high-sensitivity-c-reactive-protein","display_name":"high-sensitivity C-reactive protein","score":0.9919999837875366},{"id":"https://openalex.org/keywords/lipid-profile","display_name":"lipid profile","score":0.7250000238418579},{"id":"https://openalex.org/keywords/atherogenesis","display_name":"atherogenesis","score":0.6579999923706055},{"id":"https://openalex.org/keywords/hdl-cholesterol","display_name":"HDL cholesterol","score":0.8360000252723694},{"id":"https://openalex.org/keywords/ldl-cholesterol","display_name":"LDL cholesterol","score":0.9610000252723694},{"id":"https://openalex.org/keywords/triglycerides","display_name":"triglycerides","score":0.875},{"id":"https://openalex.org/keywords/total-cholesterol","display_name":"total cholesterol","score":0.8759999871253967}],"concepts":[{"id":"https://openalex.org/C2778096610","wikidata":"https://www.wikidata.org/wiki/Q1476525","display_name":"Dyslipidemia","level":3,"score":0.8810908794403076},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.7624344825744629},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.7599992752075195},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7464115023612976},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5993680953979492},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5857297778129578},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.5676674842834473},{"id":"https://openalex.org/C164027704","wikidata":"https://www.wikidata.org/wiki/Q3491837","display_name":"Proinflammatory cytokine","level":3,"score":0.520352303981781},{"id":"https://openalex.org/C2780942790","wikidata":"https://www.wikidata.org/wiki/Q372016","display_name":"Pathogenesis","level":2,"score":0.5092161893844604},{"id":"https://openalex.org/C2778270857","wikidata":"https://www.wikidata.org/wiki/Q2723972","display_name":"Lipid profile","level":3,"score":0.5058274269104004},{"id":"https://openalex.org/C2781195455","wikidata":"https://www.wikidata.org/wiki/Q422766","display_name":"C-reactive protein","level":3,"score":0.5020580291748047},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.4689716100692749}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:CiteSeerX.psu:10.1.1.402.4771","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.402.4771","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://www.ijabpt.com/pdf/53058-DUGGIRALA[1][1].pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":14,"referenced_works":["https://openalex.org/W1994336998","https://openalex.org/W1996737046","https://openalex.org/W2044488792","https://openalex.org/W2078040430","https://openalex.org/W2107691426","https://openalex.org/W2116404316","https://openalex.org/W2120480222","https://openalex.org/W2151025367","https://openalex.org/W2153797344","https://openalex.org/W2316376271","https://openalex.org/W2340364245","https://openalex.org/W2342149286","https://openalex.org/W2417428359","https://openalex.org/W2615584519"],"related_works":["https://openalex.org/W4288148375","https://openalex.org/W1988759813","https://openalex.org/W7098632341","https://openalex.org/W7166724829","https://openalex.org/W7219487813","https://openalex.org/W2080155990","https://openalex.org/W4403359000","https://openalex.org/W4308151892","https://openalex.org/W2407718166","https://openalex.org/W7204521187"],"abstract_inverted_index":{"ABSTRACT:":[0],"Background:":[1],"The":[2],"interplay":[3],"between":[4,184],"inflammation":[5],"and":[6,25,36,45,61,75,90,117,148,158,165,188,194],"lipids":[7,67],"has":[8],"recently":[9],"been":[10],"the":[11,18,26,56,63,83,110,200,204],"focus":[12],"of":[13,20,28,55,86,112,136,146,199,206],"research":[14],"aimed":[15],"at":[16],"understanding":[17],"development":[19],"Type":[21],"2":[22,155],"diabetes":[23,156],"mellitus":[24,157,193],"process":[27],"atherogenesis.":[29],"Inflammatory":[30],"markers":[31,65,190,202],"particularly":[32],"Tumor":[33],"necrosis":[34],"factor-\u03b1":[35],"high":[37,137],"sensitive":[38,138],"C-reactive":[39,139],"protein":[40,140],"interfere":[41],"with":[42,66,161,170],"lipid":[43,186],"homeostasis":[44],"activates":[46],"proinflammatory":[47],"mechanisms":[48],"in":[49,68,109,141,153,191,203,208],"type-2":[50],"Diabetes":[51,70],"mellitus.":[52,71,210],"Our":[53],"aim":[54],"study":[57,177],"was":[58,97,121],"to":[59],"analyze":[60],"correlate":[62],"inflammatory":[64,189,201],"Type2":[69],"50":[72,76],"diabetic":[73],"subjects":[74],"normal":[77],"healthy":[78],"controls":[79],"were":[80,107,150],"recruited":[81],"from":[82,175],"outpatient":[84],"department":[85],"Narayana":[87],"Medical":[88],"college":[89],"hospital,":[91],"Nellore,":[92],"A.P).":[93],"Serum":[94],"TNF-alpha":[95],"concentration":[96],"measured":[98],"using":[99,123],"Sandwich":[100],"ELISA":[101],"kit":[102],"method.":[103],"commercial":[104],"enzymatic":[105],"methods":[106],"used":[108,132],"determination":[111,135],"serum":[113,144],"total.cholesterol,":[114],"HDL":[115,171],"cholesterol":[116,120,164,167],"Triacylglycerides.":[118],"LDL":[119,166],"estimated":[122],"friedewald":[124],"equation.":[125],"Turbidimetric":[126],"immunoassay":[127],"(QUANTIA":[128],"CRP-":[129],"US)":[130],"is":[131,180],"for":[133],"ultrasensitive":[134],"serum.":[142],"Results:":[143],"levels":[145],"TNF-\u03b1":[147],"hs-CRP":[149],"significantly":[151],"elevated":[152],"type":[154],"correlated":[159],"positively":[160],"triacylglycerides,":[162],"total":[163],"but":[168],"negatively":[169],"cholesterol.":[172],"We":[173],"conclude":[174],"our":[176],"that":[178],"there":[179],"a":[181,196],"strong":[182],"association":[183],"proathergenic":[185],"profile":[187],"Type2Diabetes":[192],"suggests":[195],"significant":[197],"role":[198],"pathogenesis":[205],"dyslipidemia":[207],"Type2diabetes":[209]},"counts_by_year":[],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2025-10-27T00:00:00"}